Novel Treatment for Rotator Cuff Tears

Last updated: August 15, 2024
Sponsor: Mayo Clinic
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Ultrasonic tenotomy

Clinical Study ID

NCT05590494
21-011522
  • Ages 25-75
  • All Genders

Study Summary

The focus of this study is to examine changes in pain scores, strength, and range of motion over time following an ultrasonic tenotomy on a partial tear (<50%) of the supraspinatus tendon of the rotator cuff.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Evidence of partial tear (< 50%) of the supraspinatus tendon on MRI.

Exclusion

Exclusion Criteria:

  • A tear of the supraspinatus tendon greater > 50% and any areas of full thicknesstearing, concomitant tears > 25% of other rotator cuff tendons (infraspinatus, teresminor or subscapularis), or acute tear of the glenoid labrum.

  • Evidence of systemic illness/infection requiring oral or IV antibiotics during therecruitment period.

  • Evidence of overlying skin infection or lesion at the proposed device insertionpoint on the shoulder.

  • Previous corticosteroid injection within three months.

  • Those individuals less than 25 and greater than 75 years of age will be excluded.

Study Design

Total Participants: 15
Treatment Group(s): 1
Primary Treatment: Ultrasonic tenotomy
Phase:
Study Start date:
November 07, 2022
Estimated Completion Date:
June 30, 2026

Connect with a study center

  • Mayo Clinic Health System - Onalaska

    Onalaska, Wisconsin 54650
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.